Crescent Biopharma, Inc. (CBIO)
NASDAQ · Healthcare
Crescent Biopharma, Inc. Net Income 2012–2025
Crescent Biopharma, Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Crescent Biopharma, Inc. net income for the quarter ending March 31, 2026 was -23.3 M, a 53.70% increase year-over-year.
- Crescent Biopharma, Inc. net income for the twelve months ending March 31, 2026 was -69.0 M, a 37.90% increase year-over-year.
- Crescent Biopharma, Inc. annual net income for 2025 was -153.9 M, a 317.19% increase from 2023.
- Crescent Biopharma, Inc. annual net income for 2023 was -36.9 M, a 20.97% decrease from 2022.
- Crescent Biopharma, Inc. annual net income for 2022 was -46.7 M, a 26.39% decrease from 2021.
- Crescent Biopharma, Inc. annual net income for 2021 was -63.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Crescent Biopharma, Inc. Net Income — FAQ
Crescent Biopharma, Inc. (CBIO) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Crescent Biopharma, Inc.'s net income?
Crescent Biopharma, Inc. (CBIO) reported net income of -$154M for fiscal 2025.
Where can I see CBIO's net income history?
The chart and table above show Crescent Biopharma, Inc.'s net income by year and by quarter, including the growth rate.